David Berd

David Berd

Company: Biovaxys

Job title: Founder & Chief Medical Officer

Seminars:

A Novel Delivery System for Personalized Peptide & mRNA Vaccines for More Targeted Therapies 4:00 pm

The DPXâ„¢ platform is a novel delivery system for packaging multiple proteins, peptides, cancer neoantigens, viruses and viral-like particles, and polynucleotides The DPXâ„¢ package is highly versatile and can accommodate multiple peptides plus immunostimulants, such as macrophage activators DPXâ„¢ is highly stable and remains localized at the injection site, thereby avoiding potential systemic toxicitiesRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.